The proof behind the system is in the real-world evidence

Top healthcare companies trust us to help thousands of patients manage their medication schedule day after day.

hero
hero

Top healthcare companies trust us to help thousands of patients manage their medication schedule day after day.

1+ additional fills per patient per year

Consistently proven results across different therapies and disease states, published by top pharmacies and academic health centers.

Journal of Managed Care & Specialty Pharmacy (JMCP)

Avella Specialty Pharmacy, UnitedHealth Group

4.7 out of 5

overall patient satisfaction

Journal of Acquired Immune Deficiency Syndromes (JAIDS)

Weill Cornell Clinical Trials Unit

+1 additional dose,

per week, per levels in the blood

Avella Pharmacy

UnitedHealth Group

26% increased time on therapy

per patient, per year

Diplomat Pharmacy

UnitedHealth Group

19 fewer gap days

per patient, per year

US Bioservices

AmerisourceBergen

1.5 additional months on therapy

per patient, per year

Journal of Managed Care & Specialty Pharmacy (JMCP)

Avella Specialty Pharmacy, UnitedHealth Group

Peer-reviewed

In a real-world pharmacy setting, the Aidia System with pharmacist interventions was associated with increased medication adherence:

12.6% increased adherence

with more consistent dose-time behavior compared with control group

1 additional cycle

of medication taken compared with control group over 6 months

5 out of 5

(strongly agree) rating for ease of setup and ease of use

“[AdhereTech] demonstrated a significantly higher median adherence of 100% compared with the control arm median adherence of 87.4% (P=0.001).”

“[AdhereTech patients] had more regulated behavior and took a greater proportion of doses during the optimal 2-hour dosing window (83% vs 22%; P<0.001).”

“In addition to improved adherence, [AdhereTech patients] completed more cycles.”

Journal of Acquired Immune Deficiency Syndromes (JAIDS)

Weill Cornell Clinical Trials Unit

Peer-reviewed

Key study shows adherence intervention in patients with HIV, using the Aidia System, resulted in fewer missed doses of medication.

1 additional dose per week

compared with control group

Patients using AdhereTech had optimal levels of medication in the blood “on the order of around one additional dose per week” vs patients not using AdhereTech.

“Using an objective novel marker, intracellular tenofovir diphosphate by dried blood spot, demonstrates the best evidence of the use of [AdhereTech] to improve adherence.”

Conducted and published by Dr. Roy Gulick, Chief of the Division of Infectious Diseases, Former Chairman of the FDA Antiviral Drugs Advisory Committee

Avella Pharmacy

UnitedHealth Group

Analysis of patients using the Aidia System across five specialty medications showed consistent improvements in adherence, duration, refills, and patient experience compared with control groups not using the system:

15% increased adherence

at the dose-level

9% increase in fill rates

per patient, per year

1-2 additional fills

of medication per patient per year

“AdhereTech improves adherence and generates 1-2 additional fills of medication per patient per year, across multiple specialty medications and diseases.”

“Patient feedback is overwhelmingly positive, with the average patient satisfaction rating at 4.7 out of 5.”

“AdhereTech program continues to achieve stellar results for patients. One of the many benefits is that the program delivers additional support to patients or caregivers when it’s needed most, leading to a great patient experience.”

Diplomat Pharmacy

UnitedHealth Group

The Aidia System showed significant and consistent adherence and persistency improvements for patients compared with patients not using the system:

12% higher patient retention

per patient, per year

1+ additional medication fills

per patient, per year

19 fewer gap days

per patient, per year

“Over a year, the average patient using AdhereTech bottles experienced a 12% higher patient retention rate.

19 fewer gap days [annually] (time without medication between fills).”

“The average patient using AdhereTech bottles experienced more than one additional medication fill [annually].”

US Bioservices

AmerisourceBergen

18-month analysis of fill-level data for patients using the Aidia System for their medications compared with patients not using the system:

1.5 additional months on therapy

for new-to-therapy patients

1.3 additional fills dispensed

for new-to-therapy patients

1.2 additional fills dispensed

for continuing-on therapy patients

“Patients new to therapy who began treatment with the Smart Pill Bottle stayed on therapy for 1.5 additional months and had 1.3 additional fills dispensed.

“Consistently, patients continuing on a therapy had 1.2 additional fills dispensed compared to their peers not in the program.

“Patients using AdhereTech Smart Pill Bottles through US Bioservices stayed on therapy longer, refilled prescriptions more frequently.”

Partner with us

Speak with a representative about how to support your organization’s patient populations.

Contact Us